Jia Wei

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Respiratory Syndrome Coronavirus

Top Venues

American journal of hematology

Cancer medicine

Annals of hematology

Experimental hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hu Qian, Xingcheng Yang, Tingting Zhang, Ping Zou, Yicheng Zhang, Weiwei Tian, Zekai Mao, Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy. American journal of hematology (2024)
Jing An, Jie Zhao, Ping Zou, Yicheng Zhang, Junni Wei, Weiwei Tian, Jia Wei
Infections associated with CAR-T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies. Cancer medicine 13 (12) (2024)
Hu Qian, Xingcheng Yang, Tingting Zhang, Ping Zou, Yicheng Zhang, Weiwei Tian, Zekai Mao, Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy. American journal of hematology 99 (4) (2024)
Hu Qian, Xingcheng Yang, Tingting Zhang, Ping Zou, Yicheng Zhang, Weiwei Tian, Zekai Mao, Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy. American journal of hematology 99 (4) (2024)
Jing An, Jie Zhao, Ping Zou, Yicheng Zhang, Junni Wei, Weiwei Tian, Jia Wei
Infections associated with CAR-T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies. Cancer medicine 13 (12) (2024)
Hu Qian, Xingcheng Yang, Tingting Zhang, Ping Zou, Yicheng Zhang, Weiwei Tian, Zekai Mao, Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy. American journal of hematology 99 (4) (2024)
Jia Wei, Min Xiao, Zekai Mao, Na Wang, Yang Cao, Yi Xiao, Fankai Meng, Weimin Sun, Ying Wang, Xingcheng Yang, Liting Chen, Yicheng Zhang, Haichuan Zhu, Shangkun Zhang, Tongcun Zhang, Jian-Feng Zhou, Liang Huang
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT. Signal transduction and targeted therapy 7 (1) (2022)
Xingcheng Yang, Ling Ma, Xiaoying Zhang, Liang Huang, Jia Wei
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia. Experimental hematology & oncology 11 (1) (2022)
Xiangke Xin, Zheng Xu, Jia Wei, Yicheng Zhang
MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X. Cancer biology & therapy 23 (1) (2022)
Xingcheng Yang, Jia Wei, Jianfeng Zhou
Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies. Hematological oncology (2022)
Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. Journal for immunotherapy of cancer 8 (2) (2020)
Ying Wang, Qinlu Li, Li Zhu, Xia Mao, Heng Zhang, Lifang Huang, Fankai Meng, Jia Wei
Cytogenetics with flow cytometry in lymph node/extranodal tissue biopsies is sensitive to assist the early diagnosis of suspected lymphomas. Annals of hematology 96 (10) (2017)